Menu

Open Letter Leads to Peer Review Changes

The Canadian Institutes of Health Research will reverse some of the recent changes to its grant-reviewing processes after protests from researchers.

Jul 14, 2016
Jef Akst

WIKIMEDIA, MAKARISTOSA June 27 open letter to Canada’s Minister of Health Jane Philpott, now signed by more than 1,300 researchers, led to an all-day meeting between Canadian Institutes of Health Research (CIHR) President Alain Beaudet and some 50 practicing scientists. In the end, Beaudet agreed to change the newly instituted online peer review structure to a hybrid system that will begin with an online culling process but sending the top 40 percent of proposals through to face-to-face meetings between reviewers and applicants, ScienceInsider reported.

“Today is a day to rejoice,” said Beaudet, according to Science. “We’ve achieved something together.”

Whether this agreement will pacify the scientific community remains to be seen. “The devil is going to be in the details,” Jim Woodgett, director of research at the Lunenfeld-Tanenbaum Research Institute at Toronto’s Mount Sinai Hospital, told Science. “Once you’ve lost confidence in a system, you’ve got to put a lot of effort into it to restore it.”

It’s still unclear when the additional peer-review changes will be implemented, and additional points of contention, such as the restructuring of CIHR’s grant types, have yet to be addressed.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!